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Abstract
Background: To explore potential biomarkers in a meniscectomy-induced knee osteoarthritis model, at forty years
after meniscectomy.
Methods: We carried out a forty-year study of 53 patients who, as adolescents, underwent open total
meniscectomy and assessed two potential synovial and serum biomarkers, namely glycosaminoglycan (GAG) and
matrix metalloproteinase-3 (MMP-3). Of the 30 patients available for review, 8 had contralateral knee operations and
were excluded.
Of the remaining 22 patients, 17 had successful operated knee synovial fluid aspirations and 8 also had successful
contralateral control knee aspirations. GAG and MMP3 levels in the synovial fluid and peripheral serum was measured
using Alcian blue precipitation and ELISA quantification, respectively. Patients also had their knee radiographs assessed
and their radiographic osteoarthritis classified as per the Kellgren-Lawrence and Ahlbӓck systems.
Results: At forty years after meniscectomy, synovial MMP-3 levels remain increased (p = 0.0132) while GAG levels
were reduced (p = 0.0487) when compared to controls and these two levels correlate inversely. Furthermore, levels
of synovial MMP-3 significantly correlated (p = 0.0032, r = 0.7734; p = 0.0256, r = 0.5552) and GAG levels significantly
inversely correlated (p = 0.0308, r = − 0.6220; p = 0.0135, r = − 0.6024), respectively, with both radiological scoring
systems. Interestingly, we found that the levels of serum MMP-3 correlated only with the synovial fluid levels of
MMP-3 in the operated knee and not with the non-operated joint (p = 0.0252, r = 0.7706 vs. p = 0.0764, r = 0.6576).
Multiple regression analysis for patient’s quality of life based on these biomarkers revealed an almost perfect
result with an R2 of 0.9998 and a p value = 0.0087.
Conclusion: Our results suggest that serum levels of MMP3 could be used as a potential biomarker for knee
osteoarthritis, using a simple blood test. Larger cohorts are desirable in order to prove or disprove this finding.
Background
Osteoarthritis (OA), along with Alzheimer’s disease, have
been characterised as “high burden diseases with no cura-
tive treatments” by the World Health Organization (WHO)
as they both lack an identifiable biomarker (Kaplan, 2004).
OA is a severely disabling disease which affects a third
of the population over 50 years worldwide, resulting in
major socio-economic burdens (Goldring et al., 2006;
Kinds et al., 2011). Aging and mechanical injury to the
joint are the primary causes of OA; however the symp-
toms associated with OA are often not displayed until
months or years following a physical insult (Swiontkowski
et al., 2000; Vincent & Saklatvala, 2008). Common knee
injuries include direct post-traumatic injury to the articu-
lar cartilage, altered knee biomechanics from cruciate liga-
ment rupture or meniscal loss or limb malalignment;
resulting in disruption of joint biomechanics and the
joints homeostatic pathways within the articular cartilage
extracellular matrix (ECM), which in turn leads to irre-
versible cartilage destruction (Sherwood et al., 2014).
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Despite the short-medium term relief from joint in-
stability and discomfort, it has been suggested that par-
tial or total meniscectomy (affecting 61/100,000 of the
population per year) (Baker et al., 1985) has detrimental
effects that eventually lead to symptomatic and radio-
logical knee OA in up to 50% of patients within 5–15 years
and increased risk of requiring knee arthroplasty in the fu-
ture (Pengas et al., 2012a; Appel, 1970; Jorgensen et al.,
1987; Hede et al., 1992).
Radiological assessment of joint osteoarthritis relies
upon plain films as the gold standard investigation with
high resolution Magnetic Resonance Imaging (MRI) as-
sessment as a potential alternative (Eckstein et al., 2006).
It is evident that these investigations demonstrate estab-
lished disease, inadequate for early identification of the
condition, which does not always correlate with patients’
perception of symptoms or progression of the condition
(Lohmander, 2004; Lawrence et al., 1966; Hannan et al.,
2000). This may be attributed to the avascular and aneural
nature of articular cartilage, suggesting that patients pre-
senting with symptomatic osteoarthritis often have signifi-
cant and irreparable cartilage damage, ultimately resulting
in knee arthroplasty as a definitive solution.
In order to achieve an early and timely identification
of the disease, patient reported outcome measures
(PROMs) and biomarkers in isolation or in combination
with radiographs have been suggested as possible diag-
nostic adjuncts. It would be invaluable to patients and
healthcare systems if it were possible to screen high risk
patients with a biomarker investigation. The success of
biomarkers used in this context would be dependent on
their ability to indicate the onset of this biological
process and in theory respond to interventions in a
timely manner (De Gruttola et al., 2001). Several mole-
cules have been proposed as possible biomarkers of OA
two of these being glycosaminoglycans (GAGs) and
matrix metalloproteinases (MMPs).
Proteoglycans (Nagase & Matrix Metalloproteinases,
1999) are produced by chondrocytes as large hydrophilic
negatively charged polysaccharides responsible for the
compressive strength of articular cartilage. Increased levels
of MMPs have been detected following knee injury and
osteoarthritis, as these degradative enzymes play a key role
in the proteolysis of cartilage matrix molecules, including
proteoglycans (Nagase & Matrix Metalloproteinases, 1999;
Lohmander et al., 1994; Lohmander et al., 1999). Proteolysis
of proteoglycans, releasing glycosaminoglycan-containing
fragments (GAGs), is an early and critical feature of cartil-
age breakdown seen following injury such as one involving
the meniscus (Liu et al., 2017) or primary OA (Lohmander
et al., 1989) and it has been demonstrated that both GAGs
and MMPs are elevated in the synovial fluid of osteoarth-
ritic knees (Lohmander et al., 1999; Lohmander et al., 1989;
Chu et al., 2015).
In this study, the serum and synovial fluid levels of
two biomarkers are reported and compared to the
non-operated knee at a mean 40 year follow-up of a co-
hort of patients that underwent open total meniscecto-
mies as adolescents with otherwise pristine knees under
the care of a single surgeon. With abundant evidence in
the literature indicating that total meniscectomy leads to
joint degeneration, increased incidence of knee OA and
need for arthroplasty procedures (Pengas et al., 2012b;
Hoser et al., 2001; Englund & Lohmander, 2004; Rockborn
& Gillquist, 1996; Lee et al., 2006). Previous analysis of
this cohort revealed a > 4 fold increase in knee OA and
132 fold increase in knee arthroplasty. An association has
also been established between the cohort’s OA radio-
graphic findings and recorded range of motion and
PROMS (Pengas et al., 2012b), it follows that an attempt
to evaluate biomarkers for OA in this cohort is logical.
Our hypothesis is that there is a significant differ-
ence in MMP-3 and GAG levels between the oper-
ated and non-operated knees which correlates with
their serum levels, potentially allowing their use as
biomarkers in tracking disease progression in this
model of knee osteoarthritis.
Methods
Patient selection criteria
Under the care of the late Professor Ian Smillie, 313 ado-
lescent patients underwent open total meniscectomy.
One hundred of these patients that were identified as
not having any other intra-articular knee pathology at
the time of the operation were reviewed at 17 and
30 years post-operatively (Abdon et al., 1990; McNicholas
et al., 2000). At the 30-year follow-up, both knees were
evaluated radiographically in 53 patients for whom an
ethical approval to be assessed at a mean of 40 years post
operatively was obtained.
At the time of review, 7 patients had undergone a total
knee replacement, 5 had passed away, 6 were lost to
follow-up and a further 5 were unable to attend for clin-
ical evaluation. Of the 30 patients available for clinical
review, 8 had contralateral knee operations and were ex-
cluded as that knee would not be able to be used as a
control. This resulted in 22 suitable patients for our
study with no other knee intervention other than the re-
moved meniscus.
All of the suitable patients (n = 22) had blood collected
into 3 plain 6 mL EDTA vacutainer tubes for serum
MMP-3 level quantification. This was inverted 8 times
and allowed to clot at room temperature.
Patients also underwent operated and non-operated
knee aspirations. Seventeen (n = 17) yielded a successful
operated knee synovial fluid aspirate and out of those,
eight (n = 8) yielded a successful contralateral control
knee aspirate (please see addendum tables depicting the
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cohorts demographics, radiological, clinical, PROMs and
biomarkers raw values). We were not able to increase
our non-operated knee aspirate samples as knee
washout-aspiration was not granted ethical approval and
therefore was not performed. Aspirate samples were col-
lected undiluted and transferred in plain tubes.
Samples were transferred to the on-site biochemistry la-
boratory and were centrifuged. They were labelled and
stored at − 70 °C and safeguarded against repetitive
freeze-thawing cycles whilst awaiting transfer for analysis
to the biochemical laboratory at Lund University, Sweden.
MMP-3 quantification
MMP-3 values were determined by a stromelysin-trapping,
enzyme-lined immunosorbent assay (Walakovits et al.,
1992). MaxiSorp surface (96-well) plates (Nunc, Roskilde,
Denmark) were coated overnight at 4 °C with 100 l/well of
a 1.0 g/ml solution of the murine stromelysin anti-dog
monoclonal antibody MAC085 (Celltech, Slough, UK) in
phosphate buffered saline (PBS) coating solution (KPL,
Gaithersburg, MD). The plates were then washed 4 times
in a solution of 2 mM of imidazole-buffered saline and
0.02% Tween 20 (KPL, Gaithersburg, MD) and incubated
for 20 min at room temperature with 1% bovine serum al-
bumin (BSA) in PBS (BSA blocking solution; KPL) to block
nonspecific protein binding to the wells.
Subsequently the BSA was washed from the plates and
standard recombinant human prostromelysin (Merck,
Rahway, NJ) or samples of plasma were added (100 l/
well) for 1 h at room temperature. The samples were
then diluted with 0.67% BSA in PBS (BSA diluent solu-
tion; KPL). The plates were washed and then incubated
with a 10 g/ml solution of rabbit polyclonal anti-human
stromelysin IgG (Merck) in BSA diluent solution. The
plates were washed again, after which they were incubated
for 1 h at room temperature with peroxidase-labelled goat
anti-rabbit IgG (KPL) diluted to 125 ng/ml in BSA solu-
tion (100 l/well). The plates were washed again and were
incubated for 5 min with a etramethylbenzidine (TMB)–
hydrogen peroxide (H2O2) solution (0.2 g/litre TMB,
0.01% H2O2), after which the reaction was stopped by the
addition of 1 M phosphoric acid. Absorbance at 450 nm
was measured spectrophotometrically using a Multi-
scan Multisoft plate reader (Labsystems, Helsinki,
Finland) and the software Ascent 2.4.2 (Thermo
Electron, Waltham, WA).
GAG quantification
Concentration of GAG was measured by a modified
Björnsson Alcian blue precipitation (Bjornsson, 1993).
This measures Alcian blue dye binding in proportion to
the number of negative charges on GAG chains. Samples
and chondroitin sulfate standards (25 μl) were precipi-
tated for two hours at 4 °C with 0.04% w/v Alcian blue,
0.72 M guanidinium hydrochloride, 0.25% w/v Triton
X − 100, and 0.1% v/v H2SO4 (0.45 ml). The precipi-
tates were collected after centrifugation (16,000 g, 15 min,
4 °C), then dissolved in 4 M guanidinium hydrochloride,
33% v/v 1-propanol (0.25 ml), and transferred to 96-well
micro-titer plates prior to absorbance measurement at
600 nm (Larsson et al., 2009).
Radiographic analysis
Radiographic analysis included bilateral knee antero-pos-
terior weight-bearing radiographs, with the knee flexed
at 15°. These radiographs were blindly and independently
scored by two investigators (IP, AA) from a distance of
60 cm without magnifying equipment, using the
Kellgren-Lawrence (Abdon et al., 1990) and the Ahlbäck
(McNicholas et al., 2000) scoring systems for knee tibiofe-
moral joint (TFJ) OA. These are two of the most widely
accepted radiographic scoring systems for knee OA.
Statistical analysis
Data were analysed using GraphPad Prism 6 (GraphPad
Software, Inc., California, USA). The Shapiro-Wilk test
was used to test data for normality. Parametric data were
compared using a paired t-test analysis. Correlations
were analysed using the Pearson’s rank correlation co-
efficient. P-values < 0.05 were considered statistically
significant. (* denoting P < 0.05, ** denoting P < 0.005,
*** denoting P < 0.0005).
Serum MMP-3 levels can predict MMP-3 levels in the
synovial fluid of post-meniscectomy patients
Positive correlation was observed between the serum
MMP-3 and synovial MMP-3 concentrations of the oper-
ated joints (p = 0.0252, r = 0.7706) (Fig. 1a) but not with
the MMP-3 concentrations of the non-operated joints
(p = 0.0764, r = 0.6576) (Fig. 1b). Serum MMP-3 levels
could therefore potentially be utilised as a surrogate
marker of synovial MMP-3 levels in these operated knees.
Results
MMP-3 is chronically upregulated and correlates with
decreased GAG at 40 years post-meniscectomy
We compared levels of MMP-3 and GAGs in the oper-
ated and non-operated knees of the 8 patients that had
successful bilateral knee synovial fluid aspirations. Paired
analysis of the levels of MMP-3 in the synovial fluid re-
vealed that even at this late time point after surgery, the
levels of MMP3 are significantly higher in the operated
knee (p = 0.0132) (Fig. 2a), with synovial GAGs levels in
the operated joint significantly reduced (p = 0.0487) (Fig.
2b). There was an inverse correlation between the levels
MMP-3 and GAGs levels within the synovial fluid when
comparing all 16 samples from both operated and
non-operated knees (p = 0.0458, r = − 0.73810) (Fig. 2c).
Pengas et al. Journal of Experimental Orthopaedics  (2018) 5:21 Page 3 of 8
The mean values and standard deviations of GAG and
MMP-3 concentrations are presented in Table 1.
Increased synovial MMP-3 and reduced GAG levels
correlate with radiographic scores
Operated knee synovial levels of MMP-3 correlated and
GAG inversely correlated significantly with both radio-
graphic evaluation systems of Ahlb ck (p = 0.0032, r =
0.7734; p = 0.0308, r = − 0.6220) (Fig. 3a and b respect-
ively) and Kellgren-Laurence (KL) (p = 0.0256, r = 0.5552;
p = 0.0135, r = − 0.6024) (Fig. 3c and d respectively).
GAG levels, patient age and MMP-3 levels predict quality
of life in a multiple regression model
To understand how these parameters affect quality of life
40 years after meniscectomy, we built a mathematical
Fig. 1 The levels of MMP-3 in the peripheral serum correlates directly with the levels in the synovial fluid of the operated but not non-operated knee joints.
a MMP-3 protein levels in the peripheral serum plotted against the levels within the synovial fluid of the operated or b non-operated knee joints (n= 8)
Fig. 2 MMP-3 is chronically upregulated and correlates with decreased GAG content in the synovial fluid of the operated knee in patients 40 years
after meniscectomy. a MMP-3 and b GAG protein levels within the synovial fluid of patients 40 years post total meniscectomy in operated or
non-operated knees (n = 8). c Correlation of absolute GAG levels plotted against absolute MMP-3 levels in the synovial fluid all knees (n = 16)
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model in which, using clinical and biochemical parameters
we could predict the quality of life using a stepwise regres-
sion (AIC function in R) (Sakamoto & information, 1986).
The final model included age at surgery, GAG 40 years
after surgery, the change in GAGs from baseline and the
amount of the MMP-3 levels 40 years after surgery. The
coefficients are displayed in (Fig. 4) and (Table 2) and the
R script and diagnostic plots are shown in Additional file 1.
Remarkably this model predicted the quality of life (QOL)
almost perfectly, with an R2 of 0.9998 and a p value =
0.0087. Taken together, these data suggest that these fac-
tors all contribute to quality of life.
Discussion
The most interesting finding of this study is that syn-
ovial MMP-3 levels are upregulated in operated knees,
correlating with radiographic scores of OA and inversely
correlating to the drop in synovial GAG concentration.
The fact that MMP-3 levels were raised so long after the
cartilage insult indicates the presence of a chronic re-
sponse and not a short lived inflammatory one as previ-
ously suggested. Interestingly, operated knee synovial
MMP-3 levels correlated with serum MMP-3 levels,
whereas non-operated knee synovial MMP-3 levels did
not. This is an important finding, as it presents serum
MMP-3 levels as a potential and easily measurable bio-
marker for knee OA.
In addition, multiple regression analysis demonstrated
that we can measure the patient’s quality of life based on
these biomarkers, which unlike PROMs cannot be
“manipulated or exaggerated” by the patients, provid-
ing a much more robust measurement which can also
allow us to estimate the QoL a patient would likely
have after surgery.
This study also demonstrated that synovial fluid GAG
levels were reduced in operated knees compared to
non-operated knees and were inversely correlated to
both Kellgren-Laurence and Ahlb ck radiographic
scores of OA. This study confirms that the greater the
interval between meniscectomy, and synovial fluid sam-
pling, the lower the concentration of GAG observed.
In OA, a number of proteases generated by the synovial
membrane and chondrocytes damage the molecular and
Table 1 Unoperated and operated mean values and standard
deviations of MMP-3 protein and GAG content in the synovial fluid
Measured outcome Unoperated
Mean ± SD
(Range)
Operated
Mean ± SD
(Range)
p Value
MMP3 content 279.91 ± 108.57 443.08 ± 226.11 0.0132
(160.7–493.49) (171.28–812.3)
GAG content 158.18 ± 70.01 119.21 ± 80.31 0.0487
(401.3–241.1) (22.28–223.87)
Fig. 3 MMP-3 and GAG levels correlate with Ahlbӓck and Kellgren-Laurence (KL) radiographic scores. a Ahlbӓck vs GAG; b Ahlbӓck vs MMP-3;
c Kellgren-Laurence vs GAG; and d Kellgren-Laurence vs MMP-3 levels in the synovial fluid of all knees (n = 16)
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architectural structure of cartilage. They cause degrad-
ation of cartilage matrix and result in the generation of
molecular fragments which are subsequently released
from cartilage into the synovial fluid and into the systemic
circulation. Two of these hydrolysed molecules are type-II
collagen and aggrecan (Jones & Riley, 2005). Early matrix
damage and acute injury have been associated with in-
creased aggrecan proteolysis and increased levels of pro-
teoglycan fragments in the synovial fluid which however
were seen to decline with time (Lohmander et al., 1999;
Lohmander et al., 1989; Pratta et al., 2003; Dahlberg et al.,
1992; Lohmander et al., 1992; Lohmander et al., 1993;
O’Driscoll, 1998; Rothwell & Bentley, 1973). A finding
supported by Larsson et al. in a mean 18 years follow-up
post meniscectomy, measuring aggrecanase-generated
ARGS neopeptite study (Larsson et al., 2010; Larsson et
al., 2012).
When examining proteases, it seems that stromelysin
(MMP-3) and collagenase (MMP-1) are two of the most
extensively studied biomarkers (Poole, 2003). MMP-3 is
produced by synovial membrane cells and by chondro-
cytes in response to mechanical stimulation and exposure
to inflammatory cytokines (Fitzgerald et al., 2004). Al-
though not all investigators agree that there is significant
increase in the levels of MMP-3 or MMP-1 in patients
with OA (Garnero et al., 2005), increased levels of synovial
fluid MMP-3 have been detected in patients suffering with
hip and knee OA (Chen et al., 2014; Ulrich-Vinther et al.,
2003; Georgiev et al., 2018) and in smaller joint degener-
ation (Jiang et al., 2013), exhibiting greater increases as
compared with MMP-1 levels (Lohmander et al.,
1993; Ishiguro et al., 1999). Recently, elevated MMP-3
levels were highlighted in post-menisectomy subjects
(Liu et al., 2017), suggesting that it would be reason-
able to consider synovial fluid MMP-3 as a potential
biomarker for OA and perhaps a valid biomarker for
follow up in post-menisectomy patients.
We selected a model of knee OA on the background
of total meniscectomy as there is strong evidence in the
literature that total meniscectomy leads to joint degener-
ation resulting in increased incidence of knee osteoarth-
ritis (Pengas et al., 2012b; Hoser et al., 2001; Englund &
Lohmander, 2004; Rockborn & Gillquist, 1996; Lee et al.,
2006). Hence, one of the strong suits of this study lies in
the very well defined and studied cohort of patients. All
patients in this cohort underwent open meniscectomy
with a uniform operative technique and post-operative
rehabilitation protocol and their follow-up period of
40 years is unique in the published literature.
The use of biomarkers as surrogate endpoints in the
diagnosis of OA is understandably desirable to both sci-
entists and surgeons alike, however it is acknowledged
that these molecules are metabolised by other tissues
and serum levels may be affected by this; oversimplifica-
tion of their metabolic pathways should be avoided and
interpretation should be made with caution (Myers,
1999). Arguably the small number of subjects in this
truly long term follow-up study limits our ability to
reach concrete conclusions that can be generalised;
however we have indicated that MMP-3 has the po-
tential of being utilised as a marker although further
research is indicated.
An improved approach for assessment of disease pro-
gression in OA could be achieved via a ‘multisource feed-
back’, combining radiographic evaluation with PROMs
and biomarkers such as MMP-3, as the quest for a simple
and easily measurable OA biomarker continues. The fact
that this has not yet fully materialised serves to underline
the complexity of this ‘simple’ monocellular tissue.
Conclusions
Our results suggest that serum levels of MMP3 could be
used as a potential biomarker for knee osteoarthritis and
possible disease predictor, using a simple blood test. Lar-
ger cohorts are desirable in order to prove or disprove
this finding.
Fig. 4 Multiple regression model incorporating patient GAG levels
pre- and post-surgery and MMP3 levels post-surgery to predict patient
quality of life. The model shows quality of life (QoL) fits with an R2 of
0.9998 and a p value = 0.0087
Table 2 Coefficients of multiple regression analysis for patient
quality of life
Estimate Std. Error t value Pr(>|t|)
(Intercept) -1.41E + 02 4.85E + 00 −29.16 0.02182*
AgeAtSur 1.15E + 01 2.97E-01 38.61 0.01648*
Gagind40 3.92E-01 3.67E-03 106.92 0.00595**
dGAG40 −2.10E + 00 2.75E-02 −76.48 0.00832**
MMP3ind40 −1.55E-01 2.48E-03 −62.63 0.01016*
Signif. codes: 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘’ 1
Residual standard error: 0.2449 on 1 degrees of freedom
Multiple R-squared: 1, Adjusted R-squared: 0.9998
F-statistic: 7406 on 4 and 1 DF, p-value: 0.008715
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